FDA Inspection 1009630 — Andreas Reiter, M.D.
The FDA completed an inspection of Andreas Reiter, M.D. on January 27, 2017 in Mannheim. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- January 27, 2017
- Fiscal Year
- 2017
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Mannheim (Germany)
Additional Details
Clinical Investigator (CI)